In two different studies, the downregulation of UCK2 at the protein level was not observed in AZA-resistant AML cells [20,36]; however, in one of the studies, UCK2 mutations were observed in these cells, which were attributed to possible enzyme inactivation [36]. This evidence concerns the gene UCK2 and acute myeloid leukemia.